CLEPRYNZA Trademark

Trademark Overview

On Tuesday, March 5, 2019, a trademark application was filed for CLEPRYNZA with the United States Patent and Trademark Office. The USPTO has given the CLEPRYNZA trademark a serial number of 88325877. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 19, 2022. This trademark is owned by COHERUS BIOSCIENCES, INC.. The CLEPRYNZA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals used for stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation
cleprynza

General Information

Serial Number88325877
Word MarkCLEPRYNZA
Filing DateTuesday, March 5, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and Servicespharmaceuticals used for stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCOHERUS BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressREDWOOD CITY, CA 94065
Party NameCOHERUS BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressREDWOOD CITY, CA 94065

Trademark Events

Event DateEvent Description
Monday, September 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2022SOU EXTENSION 5 GRANTED
Thursday, February 10, 2022SOU EXTENSION 5 FILED
Thursday, February 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 10, 2022TEAS EXTENSION RECEIVED
Friday, August 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 11, 2021SOU EXTENSION 4 GRANTED
Wednesday, August 11, 2021SOU EXTENSION 4 FILED
Wednesday, August 11, 2021TEAS EXTENSION RECEIVED
Wednesday, January 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 11, 2021SOU EXTENSION 3 GRANTED
Monday, January 11, 2021SOU EXTENSION 3 FILED
Monday, January 11, 2021TEAS EXTENSION RECEIVED
Wednesday, July 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 27, 2020SOU EXTENSION 2 GRANTED
Monday, July 27, 2020SOU EXTENSION 2 FILED
Monday, July 27, 2020TEAS EXTENSION RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 4, 2020SOU EXTENSION 1 FILED
Tuesday, February 4, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2019ASSIGNED TO EXAMINER
Friday, March 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 8, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

cleprynza pharmaceutical treatment preparations auto immune inflammation diseases production stimulating used